Takeda Pharmaceutical Company Limited
NYSETAK heads into its June 24 results with the options market flashing the most defensive signal of the past year. The clearest story is in options positioning. The put/call ratio jumped to 2.02 on June 18 — four standard deviations above its 20-day average of 0.51 and the highest reading of the past 52 weeks. Every prior session this month had a PCR below 0.70. That single-day spike…
TAK put-call ratio hits 2.02, four standard deviations above 20-day mean of 0.51—highest level in 52 weeks, signaling extreme put demand ahead of earnings on June 24.
Short interest % of float, cost to borrow, utilization, and put/call ratio for TAK are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
TAK heads into its June 24 results with the options market flashing the most defensive signal of the past year. The clearest story is in options positioning. The put/call ratio jumped to 2.02 on June 18 — four standard…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TAK — free to start on ORTEX.
Sign up for free →Open TAK on ORTEXSnapshot as of 21 Jun 2026
Pulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live TAK data →